Over 230 patients enrolled in potential registration-enabling trial in 1L HLA-A2-negative MUM, and median PFS readout targeted by year-end 2025 95 patients enrolled ...
Kilroy Realty has opened a second phase of its Oyster Point life sciences campus — but it's attracting financial and tech ...